BEAM:NASDAQ
Beam Therapeutics Inc
$23.88
arrow_upward
+1.75%(+0.41) 1D
Oct 19, 11:15:54 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BEAM...
Open
$23.88
High
$24.15
Low
$23.50
Mkt. cap
2.47B
Avg. vol.
2.00M
Volume
323.32K
52-wk high
$38.26
52-wk low
$20.23
EPS
-$0.81
Beta
2.20
Shares outstanding
103.29M
No. of employees
540
Open
$23.88
High
$24.15
Low
$23.50
Mkt. cap
2.47B
Avg. vol.
2.00M
Volume
323.32K
52-wk high
$38.26
52-wk low
$20.23
EPS
-$0.81
Beta
2.20
Shares outstanding
103.29M
No. of employees
540
News stories
From web sources and news partners
Yahoo Finance
·
1 day ago
Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Investing.com Nigeria
·
2 days ago
Form 144 BEAM THERAPEUTICS INC. For: 17 October By Investing.com
Profile
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR base editing and prime editing, whereby single nucleotides in a DNA sequence can be enzymatically modified without producing double-strand breaks. Wikipedia
About Beam Therapeutics Inc